Clinical trial

Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

NCT04180813

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2020-03-04

PhaseN/A

Study timeline

Study start (actual)2020-03-04Date precision: day

Registry last updated2022-06-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

LinagliptinDRUG · verified · RxNorm: linagliptin

AcarboseDRUG · verified · RxNorm: acarbose

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

NanjingChina2 BeijingChina1 ShanghaiChina1 ChengduChina1 ChongqingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04180813 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.